|
Meet the Oncology Experts: An Afternoon With Frank McCormick, Ph.D., F.R.S. And Tony Reid, M.D., Ph.D. to Discuss New Molecular and Biological Approaches To Treating Cancer in the New Millennium WHAT: A post-ASCO educational briefing, sponsored by Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX - news), to discuss new approaches to treating cancer. WHO: The meeting will be hosted and led by Frank McCormick, Ph.D., F.R.S., Director of the University of California San Francisco (UCSF) Comprehensive Cancer Center and Cancer Research Institute. As one of the world`s leading authorities in cancer research today, Dr. McCormick will provide an overview and highlight what developments being made today will make the biggest impact on treatment in the coming decade. Tony Reid, M.D., Ph.D., Staff Physician at the Stanford University-affiliated Veterans Affairs Palo Alto Health Care System will discuss his clinical experience with a promising new approach to cancer therapy, CI-1042 (ONYX-015), a tumor-selective, modified adenovirus (similar to the common cold virus) that has been genetically engineered to replicate in and kill cancer cells. Dr. Reid will provide a treating physician`s perspective on how these new types of agents might affect and alter the way cancer patients are treated in the future. WHEN: Tuesday, May 22, 2001 4:30 p.m. - 6:00 p.m. EDT The post-ASCO briefing will also be available "real-time" over the Internet; go to www.onyx-pharm.com/framesets/investor.html and then click on stockholder information; the presentations will be archived on Onyx`s web site at the above address. WHERE: The Waldorf=Astoria West Foyer Room 301 Park Ave. New York, NY 10022 Contact: Helen Kim, 510-262-8737, ir@onyx-pharm.com Betsy Rosenberg, 415-221-6044, bprcomm@earthlink.net SOURCE: Onyx Pharmaceuticals, Inc. |
|
| aus der Diskussion: | onyx pharmaceut. im juhu musterdepot! |
| Autor (Datum des Eintrages): | panik (21.05.01 20:03:44) |
| Beitrag: | 34 von 229 (ID:3566054) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |